Navidea Biopharmaceuticals
Navidea Biopharmaceuticals Inc., a US-based company, develops and markets precision radiopharmaceutical diagnostics for cancer.
Founded
1988Navidea Biopharmaceuticals Inc., a US-based company, develops and markets precision radiopharmaceutical diagnostics for cancer.
Navidea Biopharmaceuticals Inc., founded in Dublin, United States, is a leader in precision medicine focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer. The company's core mission is to enhance diagnostic accuracy, clinical decision-making, and patient care through immuno-targeted products. Utilizing their proprietary Manocept™ technology, Navidea aims to create next-generation targeted diagnostics and therapies to precisely identify and treat diseases.
Notable affiliated individuals include scientific and medical experts who contribute to the company's innovative advancements. Navidea has garnered investment from various stakeholders in the biopharmaceutical industry, reflecting confidence in its mission and technology. Key achievements include the development of cutting-edge diagnostic tools that have significantly impacted clinical practices and patient outcomes. Overall, Navidea's contributions have advanced the field of precision medicine, offering hope for more effective disease management and treatment.
Companies similar to Navidea Biopharmaceuticals include NuView Life Sciences, Radiomedix, Neodiagnostix and Navitor Pharmaceuticals.
Navidea Biopharmaceuticals was founded in 1988.
Navidea Biopharmaceuticals' headquarters is located in Dublin, OH, US.
Navidea Biopharmaceuticals' most recent funding round was for $2.8M (USD) in April 2023.
As of Apr 27, 2023, Navidea Biopharmaceuticals has raised a total of $133.8M (USD).
Navidea Biopharmaceuticals has 11 employees as of Feb 6, 2024.
Neodiagnostix
neodiagnostix.com
